Limited Offer
Challenges in Pulmonary Hypertension, An Issue of Heart Failure Clinics
- 1st Edition, Volume 19-1 - November 26, 2022
- Editors: Alexander E. Sherman, Alberto M. Marra, Pietro Ameri
- Language: English
- Hardback ISBN:9 7 8 - 0 - 3 2 3 - 9 3 8 7 7 - 8
- eBook ISBN:9 7 8 - 0 - 3 2 3 - 9 3 8 7 8 - 5
In this issue of Heart Failure Clinics, guest editors Drs. Alberto M. Marra, Pietro Ameri, and Alexander E. Sherman bring their considerable expertise to Challenges in Pulmonary… Read more
Purchase options
Institutional subscription on ScienceDirect
Request a sales quote-
Contains 13 relevant, practice-oriented topics including rare forms of pulmonary hypertension; management of SARS-CoV-2 infection and COVID-19 in patients with pulmonary arterial hypertension; anabolic deficiency in pulmonary arterial hypertension; anticoagulation in pulmonary hypertension; and more.
-
Provides in-depth clinical reviews on challenges in pulmonary hypertension, offering actionable insights for clinical practice.
-
Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.
- Cover image
- Title page
- Table of Contents
- Copyright
- Contributors
- Forthcoming Issues
- Preface
- Mildly Elevated Pulmonary Hypertension: Gray Zone or Already a Disease?
- Key points
- Introduction
- Summary
- Clinics care points
- Sex- and Gender-Related Aspects in Pulmonary Hypertension
- Key points
- Introduction
- Summary
- Unusual Forms of Pulmonary Hypertension
- Key points
- Schistosomiasis
- Sarcoidosis
- Pulmonary veno-occlusive disease
- Pulmonary Langerhans’ cell histiocytosis
- Sickle cell disease
- Clinics care points
- Cardiopulmonary Exercise Testing in Pulmonary Arterial Hypertension
- Key points
- Introduction
- Discussion
- Summary
- Clinics care points
- Pulmonary Arterial Hypertension in Connective Tissue Diseases Beyond Systemic Sclerosis
- Key points
- Introduction
- Epidemiology
- Summary and future directions
- Clinics care points
- Struggling Between Liver Transplantation and Portopulmonary Hypertension
- Key points
- Introduction/history/definitions/background
- Prevalence/incidence/pathogenesis
- Clinical course
- Therapeutic options
- Surgical techniques
- Discussion
- Summary
- Clinics care points
- Microscopic Examination of Clots from Percutaneous Mechanical Embolectomies in Pulmonary Embolism
- Key points
- Introduction
- Methods
- Results
- Discussion
- Summary
- Clinics care points
- Pregnancy and Pulmonary Hypertension: From Preconception and Risk Stratification Through Pregnancy and Postpartum
- Key points
- Introduction
- Preconception counseling
- Pregnancy outcomes
- Summary
- Clinics care points
- Disclosure
- Genetics of High-Altitude Pulmonary Edema
- Key points
- Introduction
- Clues to genetic susceptibility
- Sequencing of single-nucleotide polymorphisms in patients with high-altitude pulmonary edema
- Genome-wide association studies in patients with high-altitude pulmonary edema
- Larger scale sequencing approaches
- Families with multigenerational high-altitude pulmonary edema
- Animal models for high-altitude pulmonary edema
- Future directions
- Summary
- Clinics care points
- Disclosure
- Use of Oral Anticoagulant Drugs in Patients with Pulmonary Hypertension
- Key points
- Introduction
- Definitions
- Adverse outcomes in patients with pulmonary hypertension
- Impact of oral anticoagulant on adverse outcomes in pulmonary hypertension patients
- Choice of oral anticoagulant drugs
- Guidelines recommendations
- Summary
- Clinics care points
- Funding
- Management of COVID-19 in Patients with Pulmonary Arterial Hypertension
- Key points
- Introduction
- Early evidence: could patients with pulmonary arterial hypertension have favorable outcomes during COVID-19 infection?
- Further evidence
- Management of SARS-CoV-2 infection in pulmonary arterial hypertension
- Pulmonary arterial hypertension ambulatory treatment during the pandemic
- Long-term complications of COVID-19 in relation to pulmonary vascular disease in patients without baseline pulmonary hypertension
- Summary
- Clinics care points
- Funding
- Authors’ contribution
- Impact of Hormonal-Anabolic Deficiencies in Idiopathic Pulmonary Arterial Hypertension
- Key points
- Introduction
- Material and methods
- Results
- Discussion
- Summary
- Limitations
- Clinics care points
- How to Treat Right Heart Failure. Tips for Clinicians in Everyday Practice
- Key points
- Introduction
- Summary and future clinical perspectives
- Clinics care points
- Noncoding RNAs in Pulmonary Arterial Hypertension: Current Knowledge and Translational Perspectives
- Key points
- Background
- MicroRNAs in pulmonary arterial hypertension
- Long noncoding RNAs in pulmonary arterial hypertension
- Translational perspectives
- Summary
- Disclosure
- No. of pages: 240
- Language: English
- Edition: 1
- Volume: 19-1
- Published: November 26, 2022
- Imprint: Elsevier
- Hardback ISBN: 9780323938778
- eBook ISBN: 9780323938785
AS
Alexander E. Sherman
AM
Alberto M. Marra
PA